The Food and Drug Administration has approved two Alembic generics, one tentatively. The company has received full approval for its generic of Allergan's Viibryd (vilazodone hydrochloride tablets).
Buyout speculation fueled by the late January approval of depression drug Viibryd (vilazodone) – not to mention last week's chatter after President and CEO Drew Fromkin cancelled his presentation at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback